Bioinsider recently hosted a virtual meeting on Diagnostic Landscape for COVID-19. Some of the insights presented were reported by Dr. Simon Goodman, Science and Technology Program Manager of The Antibody Society. Examining COVID-19 testing is even more critical due to a large portion of unreviewed scientific publications as a result of the urgency in understanding the virus and its detection approaches to quickly contain it.
Read more about various diagnostic approaches such as molecular, serological, and rapid testing in this report. The meeting shed light on many important topics including practical and statistical considerations for diagnostic device comparisons, the critical role of antigen in serological test development, how to develop, implement, regulate and scale diagnostic tests. A clinician’s perspective on testing and how to properly handle the pandemic with the current testing capacity was presented along with a forward-looking content on a home collection of nasal specimens to lower the barrier to SARS-CoV-2 testing.
Read the full report here.